Eli Lilly's announcement of an update on Alzheimer's disease could potentially impact the company's stock. The nature of the update, whether it's positive or negative, could influence investor sentiment and thus the stock price. As Alzheimer's disease is a major focus for Eli Lilly, this update is highly relevant and important for investors.